Smith-Magenis Syndrome Foundation UK - Slenyto Rejected Again! The Scottish Medicines Consortium (SMC) after considering the resubmission for Slenyto (prolonged release melatonin) has been unable to recommend it for use within NHS
![Sleep, Growth, and Puberty After 2 Years of Prolonged-Release Melatonin in Children With Autism Spectrum Disorder - Journal of the American Academy of Child & Adolescent Psychiatry Sleep, Growth, and Puberty After 2 Years of Prolonged-Release Melatonin in Children With Autism Spectrum Disorder - Journal of the American Academy of Child & Adolescent Psychiatry](https://www.jaacap.org/cms/attachment/d1b37b92-cdcd-4031-8f30-08a9d39a122c/gr3_lrg.jpg)
Sleep, Growth, and Puberty After 2 Years of Prolonged-Release Melatonin in Children With Autism Spectrum Disorder - Journal of the American Academy of Child & Adolescent Psychiatry
![Pharmaceuticals | Free Full-Text | Mini-Tablets: A Valid Strategy to Combine Efficacy and Safety in Pediatrics Pharmaceuticals | Free Full-Text | Mini-Tablets: A Valid Strategy to Combine Efficacy and Safety in Pediatrics](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-15-00108/article_deploy/html/images/pharmaceuticals-15-00108-g004-550.jpg)